✦ LIBER ✦

9062 The value of day 8 blood count in treatment decisions when using oral vinorelbine in non-small cell lung cancer (NSCLC) patients

✍ Scribed by Faria, A.; Myerson, J.S.; Puglisi, M.; Starling, N.; Ashley, S.; Popat, S.; O'Brien, M.E.R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The value of day 8 blood count in treatm

✍ Faria, A.; Myerson, J.S.; Puglisi, M.; Starling, N.; Ashley, S.; Popat, S.; O'Br 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

The value of day 8 blood count in treatm

✍ Myerson, J.S.; Faria, A.; Puglisi, M.; Starling, N.; Popat, S.; O’Brien, M.E.R. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 79 KB

15 Oral vinorelbine in combination with

✍ Raman, R.; Burcombe, R.J.; Beesley, S.; Shah, R.; Taylor, H. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

14 Evaluation of patient preference for

✍ Shaw, A.; Armitage, M.; Barker, L.; Quinn, J.; Booth, C.; Jeyasangar, G.; Hill, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A phase II study with vinorelbine, gemci

✍ Ginopoulos, P.; Mastronikolis, N.S.; Giannios, J.; Karana, A.; Siabi, V.; Karvel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Oral vinorelbine for the treatment of me

✍ Kanard, Anne; Jatoi, Aminah; Castillo, Rene; Geyer, Susan; Schulz, Thomas K; Fit 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 107 KB